QQQ   443.45 (+1.01%)
AAPL   178.00 (-1.52%)
MSFT   412.80 (-0.20%)
META   499.66 (+1.94%)
GOOGL   137.69 (-0.56%)
AMZN   177.89 (+0.64%)
TSLA   200.79 (-0.54%)
NVDA   818.52 (+3.46%)
NIO   5.82 (+1.22%)
AMD   199.64 (+3.69%)
BABA   74.94 (+1.23%)
T   16.93 (+0.00%)
F   12.49 (+0.40%)
MU   95.48 (+5.37%)
CGC   3.26 (-0.91%)
GE   158.79 (+1.21%)
DIS   111.60 (+0.02%)
AMC   4.42 (+2.31%)
PFE   26.54 (-0.08%)
PYPL   60.31 (-0.05%)
XOM   106.22 (+1.63%)
QQQ   443.45 (+1.01%)
AAPL   178.00 (-1.52%)
MSFT   412.80 (-0.20%)
META   499.66 (+1.94%)
GOOGL   137.69 (-0.56%)
AMZN   177.89 (+0.64%)
TSLA   200.79 (-0.54%)
NVDA   818.52 (+3.46%)
NIO   5.82 (+1.22%)
AMD   199.64 (+3.69%)
BABA   74.94 (+1.23%)
T   16.93 (+0.00%)
F   12.49 (+0.40%)
MU   95.48 (+5.37%)
CGC   3.26 (-0.91%)
GE   158.79 (+1.21%)
DIS   111.60 (+0.02%)
AMC   4.42 (+2.31%)
PFE   26.54 (-0.08%)
PYPL   60.31 (-0.05%)
XOM   106.22 (+1.63%)
QQQ   443.45 (+1.01%)
AAPL   178.00 (-1.52%)
MSFT   412.80 (-0.20%)
META   499.66 (+1.94%)
GOOGL   137.69 (-0.56%)
AMZN   177.89 (+0.64%)
TSLA   200.79 (-0.54%)
NVDA   818.52 (+3.46%)
NIO   5.82 (+1.22%)
AMD   199.64 (+3.69%)
BABA   74.94 (+1.23%)
T   16.93 (+0.00%)
F   12.49 (+0.40%)
MU   95.48 (+5.37%)
CGC   3.26 (-0.91%)
GE   158.79 (+1.21%)
DIS   111.60 (+0.02%)
AMC   4.42 (+2.31%)
PFE   26.54 (-0.08%)
PYPL   60.31 (-0.05%)
XOM   106.22 (+1.63%)
QQQ   443.45 (+1.01%)
AAPL   178.00 (-1.52%)
MSFT   412.80 (-0.20%)
META   499.66 (+1.94%)
GOOGL   137.69 (-0.56%)
AMZN   177.89 (+0.64%)
TSLA   200.79 (-0.54%)
NVDA   818.52 (+3.46%)
NIO   5.82 (+1.22%)
AMD   199.64 (+3.69%)
BABA   74.94 (+1.23%)
T   16.93 (+0.00%)
F   12.49 (+0.40%)
MU   95.48 (+5.37%)
CGC   3.26 (-0.91%)
GE   158.79 (+1.21%)
DIS   111.60 (+0.02%)
AMC   4.42 (+2.31%)
PFE   26.54 (-0.08%)
PYPL   60.31 (-0.05%)
XOM   106.22 (+1.63%)

Intuitive Surgical (ISRG) Competitors

$394.04
+8.44 (+2.19%)
(As of 11:58 AM ET)

ISRG vs. EW, SYK, AMGN, SNY, PFE, ELV, MDT, VRTX, REGN, and BMY

Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include Edwards Lifesciences (EW), Stryker (SYK), Amgen (AMGN), Sanofi (SNY), Pfizer (PFE), Elevance Health (ELV), Medtronic (MDT), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), and Bristol-Myers Squibb (BMY). These companies are all part of the "medical" sector.

Intuitive Surgical vs.

Intuitive Surgical (NASDAQ:ISRG) and Edwards Lifesciences (NYSE:EW) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, community ranking, risk, earnings, dividends and valuation.

Intuitive Surgical has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Comparatively, Edwards Lifesciences has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500.

Intuitive Surgical currently has a consensus price target of $371.60, indicating a potential downside of 3.63%. Edwards Lifesciences has a consensus price target of $87.38, indicating a potential upside of 2.95%. Given Edwards Lifesciences' higher possible upside, analysts clearly believe Edwards Lifesciences is more favorable than Intuitive Surgical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Intuitive Surgical
0 Sell rating(s)
4 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
2.80
Edwards Lifesciences
1 Sell rating(s)
7 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.44

Intuitive Surgical has higher revenue and earnings than Edwards Lifesciences. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Intuitive Surgical$7.12B19.07$1.80B$5.0376.66
Edwards Lifesciences$6.00B8.50$1.40B$2.3036.90

Edwards Lifesciences received 290 more outperform votes than Intuitive Surgical when rated by MarketBeat users. Likewise, 71.89% of users gave Edwards Lifesciences an outperform vote while only 68.97% of users gave Intuitive Surgical an outperform vote.

CompanyUnderperformOutperform
Intuitive SurgicalOutperform Votes
1009
68.97%
Underperform Votes
454
31.03%
Edwards LifesciencesOutperform Votes
1299
71.89%
Underperform Votes
508
28.11%

Intuitive Surgical has a net margin of 25.24% compared to Edwards Lifesciences' net margin of 23.35%. Edwards Lifesciences' return on equity of 23.56% beat Intuitive Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
Intuitive Surgical25.24% 13.11% 11.31%
Edwards Lifesciences 23.35%23.56%16.81%

82.9% of Intuitive Surgical shares are owned by institutional investors. Comparatively, 79.3% of Edwards Lifesciences shares are owned by institutional investors. 0.9% of Intuitive Surgical shares are owned by insiders. Comparatively, 1.3% of Edwards Lifesciences shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, Intuitive Surgical had 3 more articles in the media than Edwards Lifesciences. MarketBeat recorded 23 mentions for Intuitive Surgical and 20 mentions for Edwards Lifesciences. Intuitive Surgical's average media sentiment score of 0.72 beat Edwards Lifesciences' score of 0.65 indicating that Intuitive Surgical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Intuitive Surgical
11 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Edwards Lifesciences
8 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Intuitive Surgical beats Edwards Lifesciences on 12 of the 18 factors compared between the two stocks.


Get Intuitive Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ISRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ISRG vs. The Competition

MetricIntuitive SurgicalSurgical appliances & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$136.21B$8.77B$4.96B$7.50B
Dividend YieldN/A1.07%2.88%3.87%
P/E Ratio76.6615.03196.6214.91
Price / Sales19.0759.403,036.89173.41
Price / Cash71.2820.5496.2355.17
Price / Book10.143.414.464.66
Net Income$1.80B$156.26M$114.21M$211.48M
7 Day Performance-1.07%6.14%4.26%2.63%
1 Month Performance0.46%7.15%8.76%5.46%
1 Year Performance69.62%-11.13%12.18%8.67%

Intuitive Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
EW
Edwards Lifesciences
4.2759 of 5 stars
$86.50
+0.4%
$87.38
+1.0%
+5.5%$52.01B$6.00B37.6119,800Insider Selling
Analyst Revision
SYK
Stryker
4.9389 of 5 stars
$352.21
-0.1%
$331.52
-5.9%
+32.8%$133.82B$20.50B42.6952,000
AMGN
Amgen
4.8275 of 5 stars
$278.49
-2.8%
$295.30
+6.0%
+18.2%$149.25B$28.19B22.3026,700Short Interest ↑
Analyst Revision
SNY
Sanofi
3.4458 of 5 stars
$48.21
+0.0%
$57.50
+19.3%
+2.1%$121.95B$46.61B20.4391,573Analyst Downgrade
PFE
Pfizer
5 of 5 stars
$26.89
-1.1%
$36.88
+37.1%
-34.6%$151.84B$58.50B74.6988,000Analyst Report
ELV
Elevance Health
4.4035 of 5 stars
$507.63
+0.2%
$567.90
+11.9%
+6.7%$118.11B$171.34B20.17104,900Short Interest ↓
Positive News
MDT
Medtronic
4.8197 of 5 stars
$83.85
+0.2%
$94.91
+13.2%
+0.7%$111.49B$31.23B26.7095,000
VRTX
Vertex Pharmaceuticals
4.1838 of 5 stars
$430.92
-0.6%
$417.27
-3.2%
+44.9%$111.31B$9.87B31.025,400Insider Selling
Short Interest ↑
Analyst Revision
REGN
Regeneron Pharmaceuticals
4.0616 of 5 stars
$993.35
+0.4%
$942.41
-5.1%
+27.0%$109.03B$13.12B28.5913,450Analyst Report
BMY
Bristol-Myers Squibb
4.689 of 5 stars
$50.51
0.0%
$61.17
+21.1%
-26.4%$102.13B$45.01B13.0834,100Analyst Upgrade
Analyst Revision

Related Companies and Tools

This page (NASDAQ:ISRG) was last updated on 3/1/2024 by MarketBeat.com Staff